Haemostatic gene polymorphisms in young Indian Asian subjects with acute myocardial infarction

Medical Science Monitor

Volumn 9, Issue 10, 2003, Pages

  Ranjith, Naresh ^a   Pegoraro, Rosemary J ^a   Rom, Lee ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

FactorV; Indian asian; Myocardial infarction; Polymorphism; Prothrombin; Thrombomodulin

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; THROMBOMODULIN;

ACUTE HEART INFARCTION; ADULT; ALLELE; ARTERY DISEASE; ARTICLE; ASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; HUMAN; INDIAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; RISK FACTOR;

ADOLESCENT; ADULT; ALLELES; FACTOR V; FAMILY HEALTH; GENOTYPE; HEMOSTASIS; HETEROZYGOTE; HUMANS; INDIA; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; SMOKING; THROMBOMODULIN; VALINE;

EID: 0142184231     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bertina RM, Koeleman BP, Koster T et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994; 369: 64-7
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′(-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996; 88: 3698-703
3. Ridker PM, Hennekens CH, Lindpaintner K et al: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. New Engl J Med, 1995; 332: 912-7
4. Eikelboom JW, Baker RI, Parsons R et al: No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost, 1998; 80: 878-80
5. Vargas M, Soto I, Pinto CR et al: The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease. Blood Coagul Fibrinolysis, 1999; 10: 39-41
6. Russo C, Girelli D, Olivieri O et al: G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation, 2001; 103: 2436-40
7. Abu-Amero KK, Wyngaard CA, Kambouris M, Dzimiri N: Prevalence of the 20210 G→A prothrombin variant and its association with coronary artery disease in a Middle Eastern Arab population. Arch Pathol Lab Med, 2002; 126: 1087-90
8. Juul K, Tybjaerg-Hansen A et al: Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood, 2002; 100: 3-10
9. Doggen CJ, Cats VM, Bertina RM, Rosendaal FR: Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation, 1998; 97: 1037-41
10. Gardemann A, Arsic T, Katz N et al: The factor II G202101A and factor V G1691A gene transitions and coronary heart disease. Thromb Haemost, 1999; 81: 208-13
11. Sykes TC, Fegan C, Mosquera D: Thrombophilia, polymorphisms and vascular disease. Mol Pathol, 2000; 53: 300-6
12. Franco RF, Reitsma PH. Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease. Br J Haemat, 2001; 115: 491-506
13. Norlund L, Holm J, Zoller B, Ohlin AK. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost, 1997; 77: 248-251
14. Van der Velden PA, Krommenhock-Van Es T, Alaart CF et al: A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia. Thromb. Haemost, 1991; 65: 511-3
15. Seedat YK, Mayet FGH: Coronary heart disease in South African Indians: role of insulin resistance and hypertension. J Hum Hyperten, 1993; 7: 525-7
16. Irani-Hakime N, Tamin H, Elias G et al: Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease. J Thromb Thrombolysis, 2001; 11: 111-6
17. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet, 1995; 346: 1133-4
18. Mansourati J, Da Costa A, Munier S et al: Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost, 2000, 83: 822-5
19. Doggen CJ, Kunz G, Rosendall FR et al: A mutation in the thrombomodulin gene 127 G to A coding for Ala25 Thr and the risk of myocardial infarction in men. Thromb Haemost, 1988; 80: 743-8
20. Bertina RM: Molecular risk factors for thrombosis. Thromb Haemost, 1999; 82 601-9
21. Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood, 2000; 95: 1517-32
22. Lillicrap D: The gentics of venous and arterial thromboembolism. Curr Atheroscler Rep, 2002; 3: 209-15
23. Kottke-Marchant: Genetic polymorphisms in cardiovascular disease. Arch Pathol Lab Med, 2002; 126: 295-304
24. Franco RF, Santos SE, Elion J et al: The prevalence of the G20210A polymorphism in the 3′-untranslated region of the prothrombin gene in difference human populations. Acta Haematologica, 1998; 100: 9-12
25. Lunghi B, Castoldi E, Mingozzi F, Bernardi F: A new factor V gene polymorphism (His1254Arg) present in subjects of African origin mimics the R2 polymorphism (His1299Arg)]. Blood, 1998; 91: 364-5
26. Chan WP, Lee CK, Kwong YL et al: A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood, 1998; 91: 1135-9
27. Le W, Yu JD, Lu L et al: Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population. Clin Genet, 2000; 57: 296-303
28. Ireland H, Kunz G, Kyriakoulis K et al: Thrombomodulin gene mutations associated with myocardial infarction. Circulation, 1997; 96: 15-8
29. Kunz G, Ohlin AK, Adam A et al: Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function. Blood, 2002; 99: 3646-53
30. Li YH, Chen JH, Tsai WC et al: Synegistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost, 2002; 87: 86-91